0003-1100 : Cobenfy Oral Capsule, Coated Pellets
| NDC: | 0003-1100 |
| Labeler: | E.r. Squibb & Sons, L.L.C. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Cobenfy |
| Dosage Form: | Oral Capsule, Coated Pellets |
| Application #: | NDA216158 |
| Rev. Date: |
NDC Package Codes:
- 0003-1100-14: 14 CAPSULE, COATED PELLETS IN 1 BLISTER PACK (0003‑1100‑14)
- 0003-1100-60: 60 CAPSULE, COATED PELLETS IN 1 BOTTLE (0003‑1100‑60)
Active Ingredients:
- Trospium Chloride
- Xanomeline
Dosage Strength:
- 20 mg
- 100 mg
Pharmaceutical Classes:
- Cholinergic Muscarinic Agonist [EPC]
- Cholinergic Muscarinic Agonists [MoA]
- Cholinergic Muscarinic Antagonist [EPC]
- Cholinergic Muscarinic Antagonists [MoA]
- Cytochrome P450 3A4 Inhibitors [MoA]
- P-Glycoprotein Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0003-0050 Cobenfy Oral Capsule, Coated Pellets by E.r. Squibb & Sons, L.L.C.
- 0003-0125 Cobenfy Oral Capsule, Coated Pellets by E.r. Squibb & Sons, L.L.C.
- 0003-5150 CobenfyCobenfy Kit by E.r. Squibb & Sons, L.L.C.
- 0003-5200 CobenfyCobenfy Kit by E.r. Squibb & Sons, L.L.C.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0003-0895Next: 0003-1427 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.